Rho (D) immune globulin

INDICATIONS

FDA

  • Suppression of Rh isoimmunization in non-sensitized, Rho (D) negative women to reduce likelihood of hemolytic disease in Rho (D) -positive fetus in present and future pregnancies.
  • Treatment of ITP (including ITP secondary to HIV) in non-splenectomized, Rho (D)-positive pts.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: February 22, 2011